1887

Chapter 9 : The Looming Crisis in Antibiotic Availability

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $7.00

Preview this chapter:
Zoom in
Zoomout

The Looming Crisis in Antibiotic Availability, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817602/9781555812980_Chap09-1.gif /docserver/preview/fulltext/10.1128/9781555817602/9781555812980_Chap09-2.gif

Abstract:

There are three responses to the antibiotic resistance problem. One is to try to educate physicians and patients about the appropriate use of antibiotics, in the hope that education programs will change the behavior of both groups. A second response would be to limit a physician’s freedom to prescribe antibiotics by placing veto power in the hands of a pharmacist or infectious disease specialist. A third response would be to step up the discovery of new antibiotics. It is true that the profitability of antibiotics is not as great as that of drugs for treating neurological diseases, heart disease, cancer, and depression. Vancomycin was hailed as the solution to methicillin-resistant (MRSA) infections, but vancomycin-resistant strains of have already begun to emerge. These strains have so far been susceptible to at least one other antibiotic, but the fact that can become resistant to vancomycin raises the specter of the future evolution of a strain that is resistant to all available antibiotics. One suggestion for encouraging the pharmaceutical companies to reenter the antibiotic discovery area is to make antibiotics “orphan drugs.” Patients who see their medical costs spiraling out of control might find this “pill” hard to swallow because it would keep drug prices higher longer, but drugs are a relatively minor component of medical costs as a whole.

Citation: Salyers A, Whitt D. 2005. The Looming Crisis in Antibiotic Availability, p 116-129. In Revenge of the Microbes. ASM Press, Washington, DC. doi: 10.1128/9781555817602.ch9

Key Concept Ranking

Bacterial Pathogenesis
0.46403518
Urinary Tract Infections
0.44429547
Crohn's Disease
0.43030217
Bacterial Diseases
0.40258628
0.46403518
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 9.1
Figure 9.1

The process required for the approval of a new antibiotic.

Citation: Salyers A, Whitt D. 2005. The Looming Crisis in Antibiotic Availability, p 116-129. In Revenge of the Microbes. ASM Press, Washington, DC. doi: 10.1128/9781555817602.ch9
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555817602.chap09

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error